0001437749-15-000927.txt : 20150121
0001437749-15-000927.hdr.sgml : 20150121
20150121164607
ACCESSION NUMBER: 0001437749-15-000927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150116
FILED AS OF DATE: 20150121
DATE AS OF CHANGE: 20150121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wrighton-Smith Peter
CENTRAL INDEX KEY: 0001592286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 15539025
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-01-16
0001586049
Oxford Immunotec Global PLC
OXFD
0001592286
Wrighton-Smith Peter
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
1
Chief Executive Officer
Share Option (Right to Buy)
14.57
2015-01-16
4
A
0
51403
0
A
2025-01-16
Ordinary Shares
51403
51403
D
Option granted under Issuer's 2013 Share Incentive Plan.
Options will become exercisable ratably on the first day of each month from February 1, 2015 through January 1, 2019.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact
2015-01-21